Is there benefit to high-dose aspirin for antiplatelet effect?

No. COX-1 inhibition (platelet thromboxane A2 inhibition) is maximally achieved at 75–100 mg. Doses >100 mg do not add antiplatelet benefit and increase GI bleeding risk 2–3×. Post-ACS and DAPT: 81 mg is standard (some prefer 325 mg loading then 81 mg maintenance). ASCEND/ARRIVE/ASPREE showed no net benefit for primary prevention.

When is aspirin 325 mg used vs 81 mg?

325 mg: acute ACS loading (single dose) and in the first 1–3 months post-bare metal or drug-eluting stent placement per some protocols, then reduced to 81 mg. Peripheral arterial disease: 100 mg preferred. Stroke secondary prevention: 50–325 mg (most guidelines 100 mg). Higher doses only increase bleeding without additional platelet inhibition.

Aspirin Dose for Antiplatelet Effect Optimization

Determine optimal aspirin dose for antiplatelet effect by indication: 75–100 mg for secondary CVD prevention and DAPT with PCI, 81 mg for primary prevention in selected patients, 325 mg for ACS acute loading.

Use the full interactive calculator below, or

Aspirin Dose for Antiplatelet Effect Optimization

Frequently Asked Questions

Is there benefit to high-dose aspirin for antiplatelet effect?

When is aspirin 325 mg used vs 81 mg?